Lepu Medical Technology (Beijing) Co., Ltd.
300003
Kedudukan dalam Saham
#4734
Established in 1999 and headquartered in Beijing, China, Lepu Medical... Established in 1999 and headquartered in Beijing, China, Lepu Medical Technology is a prominent company dedicated to the research, development, production, and sale of a broad spectrum of medical devices, pharmaceuticals, and healthcare services. The company's extensive medical device portfolio primarily focuses on cardiovascular health. This includes interventional cardiology products such as coronary stents, balloons, catheters, guide wires, and related PCI accessories. It also provides solutions for structural heart diseases, like occluders, vascular plugs, delivery systems, and mechanical heart valves. Lepu Medical offers cardiac rhythm management products, including pacemakers, equipment, leads, and electrophysiology systems, alongside products for off-pump coronary artery bypass grafting and peripheral interventional devices such as PTA balloons and guide wires. Beyond cardiovascular applications, their offerings extend to critical care products like vascular access devices, needle-free connectors, blood samplers, and pressure transducers. The company also provides digital subtraction angiography (DSA) systems (both floor and suspended types), in vitro diagnostic (IVD) equipment and biomarkers, hemodialysis catheters and hollow fiber dialyzers, and general surgery instruments including surgical staplers and endo surgery accessories. In the pharmaceutical sector, Lepu Medical manufactures and distributes medications for various conditions. This encompasses a comprehensive range of cardiovascular drugs designed to treat issues like thrombosis, hyperlipidemia, hypertension, angina, and heart failure. Additionally, they produce beta-lactamase antibiotics and antifungal antimicrobial drugs, central nervous system medications (such as painkillers and antidepressants), treatments for gastric/duodenal ulcers and chronic liver disease, respiratory system drugs, hypoproteinemia drugs, and agents that activate blood circulation. Furthermore, Lepu Medical provides a diverse array of healthcare services. These include precision medicine, remote ECG telemonitoring, and specialized consulting and management centers for cardiovascular diseases. The company is also involved in medical science and technology incubation, equity investment, and offers medical financial services. Its service offerings extend to general health consultation, online pharmacy platforms, sales of household medical equipment, smart medical devices, and the operation of specialized hospitals focusing on cardiovascular care. Lepu Medical actively participates in the establishment and co-construction of cardiac catheterization laboratories (Cath Labs).
Harga Saham
$1.74
Modal Pasaran
$3.21B
Perubahan (1 hari)
3.62%
Perubahan (1 tahun)
-31.70%
Negara
CN
Perdagangan Lepu Medical Technology (Beijing) Co., Ltd. (300003)
Kategori
Healthcare
Nisbah P/E bagi Lepu Medical Technology (Beijing) Co., Ltd. (300003)
Nisbah P/E pada October 2026 TTM: 26.94
Menurut laporan kewangan dan harga saham terkini Lepu Medical Technology (Beijing) Co., Ltd., nisbah P/E semasa (TTM) ialah 26.94. Pada akhir 2023, syarikat mempunyai nisbah P/E sebanyak 23.68.
Sejarah nisbah P/E bagi Lepu Medical Technology (Beijing) Co., Ltd. dari 2006 hingga 2026
Nisbah P/E pada akhir setiap tahun
| Tahun | Nisbah P/E | Ubah |
|---|---|---|
| 2026 (TTM) | 26.94 | -68.26% |
| 2024 | 84.88 | 258.42% |
| 2023 | 23.68 | 26.07% |
| 2022 | 18.78 | -20.35% |
| 2021 | 23.58 | -12.01% |
| 2020 | 26.80 | -21.04% |
| 2019 | 33.94 | 15.62% |
| 2018 | 29.36 | -36.13% |
| 2017 | 45.97 | 0.31% |
| 2016 | 45.82 | -23.84% |
| 2015 | 60.16 | 31.75% |
| 2014 | 45.66 | 21.35% |
| 2013 | 37.63 | 104.00% |
| 2012 | 18.45 | -21.43% |
| 2011 | 23.48 | -56.69% |
| 2010 | 54.20 | -17.55% |
| 2009 | 65.74 | -42.79% |
| 2008 | 114.92 | -10.24% |
| 2007 | 128.03 | 5.55% |
| 2006 | 121.29 | 0.00% |
Nisbah P/E untuk syarikat serupa atau pesaing
| Syarikat | Nisbah P/E | Perbezaan Nisbah P/E | Negara |
|---|---|---|---|
| 33.11 | 22.91% |
US
|
|
| 21.39 | -20.61% |
IE
|
|
| 28.94 | 7.45% |
US
|
|
| 17.34 | -35.64% |
US
|
|
| - | - |
DE
|
Cara membaca nisbah P/E
Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.
Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.
Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.